Literature DB >> 21375496

The gp130 receptor cytokine family: regulators of adipocyte development and function.

Ursula A White1, Jacqueline M Stephens.   

Abstract

Gp130 cytokines are involved in the regulation of numerous biological processes, including hematopoiesis, immune response, inflammation, cardiovascular action, and neuronal survival. These cytokines share glycoprotein 130 as a common signal transducer in their receptor complex and typically activate STAT3. Most gp130 cytokines have paracrine or endocrine actions, and their levels can be measured in circulation in rodents and humans. In recent years, various laboratories have conducted studies to demonstrate that gp130 cytokines can modulate adipocyte development and function. Therefore, these studies suggest that some gp130 cytokines may be viable anti-obesity therapeutics. In this review, we will summarize the reported effects of gp130 cytokines on adipocyte differentiation and adipocyte function. In addition, the modulation of gp130 cytokines in conditions of obesity, insulin resistance, and Type 2 diabetes will be presented.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375496      PMCID: PMC3119891          DOI: 10.2174/138161211795164202

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  122 in total

Review 1.  Interleukin-6 and diabetes: the good, the bad, or the indifferent?

Authors:  Ole P Kristiansen; Thomas Mandrup-Poulsen
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Cross-talk among gp130 cytokines in adipocytes.

Authors:  Sanjin Zvonic; James E Baugh; Patricia Arbour-Reily; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2005-08-11       Impact factor: 5.157

3.  Effects of leukemia inhibitory factor on 3T3-L1 adipocytes.

Authors:  Jessica C Hogan; Jacqueline M Stephens
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

4.  Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

Authors:  Peter J Klover; Alicia H Clementi; Robert A Mooney
Journal:  Endocrinology       Date:  2005-04-21       Impact factor: 4.736

5.  Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch.

Authors:  Chris J Pemberton; Sara D Raudsepp; Tim G Yandle; Vicky A Cameron; A Mark Richards
Journal:  Cardiovasc Res       Date:  2005-10-01       Impact factor: 10.787

6.  Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.

Authors:  Lalita Khaodhiar; Pei-Ra Ling; George L Blackburn; Bruce R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

7.  Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro.

Authors:  Maria E Trujillo; Sean Sullivan; Ingrid Harten; Stephen H Schneider; Andrew S Greenberg; Susan K Fried
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

8.  Interleukin 11 signaling in 3T3-L1 adipocytes.

Authors:  Raleigh Tenney; Karrie Stansfield; Phillip H Pekala
Journal:  J Cell Physiol       Date:  2005-01       Impact factor: 6.384

9.  Effects of cardiotrophin on adipocytes.

Authors:  Sanjin Zvonic; Jessica C Hogan; Patricia Arbour-Reily; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2004-08-31       Impact factor: 5.157

10.  Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro.

Authors:  E W Petersen; A L Carey; M Sacchetti; G R Steinberg; S L Macaulay; M A Febbraio; B K Pedersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-21       Impact factor: 4.310

View more
  26 in total

Review 1.  Role of interleukin-6 in cachexia: therapeutic implications.

Authors:  Aditi A Narsale; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

Review 2.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

3.  Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Faridoddin Mirshahi; Aurora Verdianelli; Tommy Pacana; Vaishali Patel; Chun-Geon Park; Aejin Choi; Jeong-Hoon Lee; Chung-Berm Park; Shunlin Ren; Arun J Sanyal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-06       Impact factor: 4.052

4.  Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.

Authors:  Shuhong Sun; Ran Wang; Jianwen Song; Ming Guan; Na Li; Xiaotian Zhang; Zhenwen Zhao; Junjie Zhang
Journal:  J Lipid Res       Date:  2017-09-05       Impact factor: 5.922

Review 5.  Inborn errors of human JAKs and STATs.

Authors:  Jean-Laurent Casanova; Steven M Holland; Luigi D Notarangelo
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

6.  β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130.

Authors:  Leiluo Geng; Boya Liao; Leigang Jin; Jiasui Yu; Xiaoyu Zhao; Yuntao Zhao; Ling Zhong; Baile Wang; Jiufeng Li; Jie Liu; Jin-Kui Yang; Wei Jia; Qizhou Lian; Aimin Xu
Journal:  Nat Metab       Date:  2022-05-12

7.  Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor.

Authors:  Xin Chen; Bryan S Hausman; Guangbin Luo; Guang Zhou; Shunichi Murakami; Janet Rubin; Edward M Greenfield
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

Review 8.  The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release.

Authors:  Stephan Wueest; Daniel Konrad
Journal:  Adipocyte       Date:  2018-08-03       Impact factor: 4.534

Review 9.  Review: the Roles and Mechanisms of Glycoprotein 130 Cytokines in the Regulation of Adipocyte Biological Function.

Authors:  Dufang Ma; Yong Wang; Guofeng Zhou; Yongcheng Wang; Xiao Li
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

10.  Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model.

Authors:  S Hazra; Y P R Jarajapu; V Stepps; S Caballero; J S Thinschmidt; L Sautina; N Bengtsson; S Licalzi; J Dominguez; T S Kern; M S Segal; J D Ash; D R Saban; S H Bartelmez; M B Grant
Journal:  Diabetologia       Date:  2012-11-29       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.